New research by vulnerability management platform Outpost24 warns 80% of the European Union (EU)'s top pharmaceutical companies are "critically exposed" to cyberattack due to poor security postures.
Outpost24 designated 3.3% of Web applications run by the businesses as "suspicious," including open test environments that should have been closed.
Moreover, 18% of organizations use outdated, unpatched Web elements with known flaws, while over 200 EU pharmaceutical application forms operate without encryption, elevating the risk of interception and theft of users' information.
View Full Article
Abstracts Copyright © 2021 SmithBucklin, Washington, DC, USA